These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2487564)

  • 1. Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches.
    Claas FH; de Waal LP; Beelen J; Reekers P; Berg-Loonen PV; de Gast E; D'Amaro J; Persijn GG; Zantvoort F; van Rood JJ
    Clin Transpl; 1989; ():185-90. PubMed ID: 2487564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending options for highly sensitized patients to receive a suitable kidney graft.
    Doxiadis II; Duquesnoy RJ; Claas FH
    Curr Opin Immunol; 2005 Oct; 17(5):536-40. PubMed ID: 16084709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the highly sensitized patient.
    Claas FH; Doxiadis II
    Curr Opin Immunol; 2009 Oct; 21(5):569-72. PubMed ID: 19682882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making.
    van Rood JJ; Lagaaij EL; Doxiadis I; Roelen D; Persijn G; Claas F
    Clin Transpl; 1993; ():285-92. PubMed ID: 7918162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
    van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH
    Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
    Vaidya S
    Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.